Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
32.58
-0.30 (-0.91%)
Jun 27, 2025, 4:00 PM - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.20 billion as of June 27, 2025. Its market cap has decreased by -46.26% in one year.
Market Cap
4.20B
Enterprise Value
2.62B
1-Year Change
-46.26%
Ranking
Category
Stock Price
$32.58
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.20B, an increase of 204.57%. That is a compound annual growth rate of 24.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 4.24B | -58.43% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |